1361021-39-7 Usage
Explanation
Different sources of media describe the Explanation of 1361021-39-7 differently. You can refer to the following data:
1. The molecular formula represents the number of atoms of each element present in a molecule of the compound.
2. 1-Bromo-4-iodo-2-methoxy-5-nitro-benzene is derived from benzene, a basic aromatic hydrocarbon, by attaching various functional groups to its structure.
3. These are the specific functional groups attached to the benzene ring, which give the compound its unique chemical properties and reactivity.
4. The compound is used as a building block in the synthesis of various organic compounds, including pharmaceuticals and agrochemicals.
5. Due to its multiple functional groups, 1-Bromo-4-iodo-2-methoxy-5-nitro-benzene can be used in a wide range of chemical reactions and applications.
6. The compound is known for its high reactivity, which allows it to participate in various chemical reactions, such as nucleophilic substitution and metal-catalyzed cross-coupling reactions.
7. The compound has potential applications in the development of new materials and polymers, thanks to its unique structure and reactivity.
8. These are two common types of chemical reactions that 1-Bromo-4-iodo-2-methoxy-5-nitro-benzene can undergo, which contribute to its utility in organic synthesis and material science.
Derivative of benzene
Yes
Functional groups
Bromine, Iodine, Methoxy, and Nitro
Use in organic synthesis
Yes
Versatility
High
Reactivity
High
Applications in material science
Yes
Chemical reactions
Nucleophilic substitution and metal-catalyzed cross-coupling
Check Digit Verification of cas no
The CAS Registry Mumber 1361021-39-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,1,0,2 and 1 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1361021-39:
(9*1)+(8*3)+(7*6)+(6*1)+(5*0)+(4*2)+(3*1)+(2*3)+(1*9)=107
107 % 10 = 7
So 1361021-39-7 is a valid CAS Registry Number.
1361021-39-7Relevant articles and documents
COMBINATION THERAPY
-
, (2021/10/02)
The invention provides a combinations and pharmaceutical compositions comprising (i) a compound which is an indane according to Formula (I) or a pharmaceutically acceptable salt thereof; and (ii) one or more CFTR modulator; wherein R1, R2
METHODS AND COMPOSITIONS FOR MODULATING SPLICING
-
, (2020/08/22)
Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.
Conformationally restricted dynamic supramolecular catalysts for substrate-selective epoxidations
Sheibani, Esmaeil,Waernmark, Kenneth
, p. 2059 - 2067 (2012/04/23)
A second generation of a substrate-selective dynamic supramolecular catalytic system consisting of a catalyst part and a receptor part, connected by a hydrogen-bonding motif, has been realized based on rational design. The results from analyses of the equilibrium mixture of the species generated by the components of the first generation system led us to selectively lock the cisoid conformation of the catalyst part to increase the amount of the substrate-selective catalytic cavity in the equilibrium mixture. This was realized by strapping the catalyst part by organic synthesis. This strapping led to an increase in substrate selectivity in the pair-wise competitive epoxidations of pyridyl- vs. phenyl-appended styrenes and pyridyl- vs. phenyl-appended stilbenes of both Z- and E- configuration compared to the first generation system, reaching 3.4:1 as the highest substrate selectivity for Z-mono-pyridyl-stilbene (27a) vs. the corresponding all-carbon analogue (28a) and for E-dipyridyl-stilbene (26b) vs. the corresponding all-carbon analogue (28b), respectively.
